Melita Irving
Tumor immunology


Undergraduate, University of Waterloo, Canada

PhD, Simon Fraser University, Canada

Post-Doc, Terry Fox Laboratory, BC Cancer Research Center and Centre Pluridisciplinaire d'Oncologie (Cepo), University Hospital of Lausanne (CHUV)

My research focus is on the development of gene-engineered T cells, tailored to treat specific tumours, that enable or promote tumor-targeting, productive T-cell signalling and metabolic activity under suppressive conditions, tumor microenvironment re-programming to foster immunity and safety.

Ludwig Institute for Cancer Research, Lausanne
Agora Research Center
Rue du Bugnon 25A, CH-1005 Lausanne

T (41) 21 545 10 77
F (41) 21 692 59 95


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?